CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT01395745 · COMPLETED
Trial details
- NCT number
- NCT01395745
- Sponsor
- Anthera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.